Format

Send to

Choose Destination
J Allergy Clin Immunol. 2017 Sep;140(3):864-867.e5. doi: 10.1016/j.jaci.2017.01.043. Epub 2017 Apr 4.

Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.

Author information

1
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
2
Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
3
Department of Dermatology and Allergy, RWTH Aachen University, Aachen, Germany.
4
Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.
PMID:
28389393
DOI:
10.1016/j.jaci.2017.01.043
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center